sefulness of Individualized Homoeopathic Treatment in The Management of Glycated Haemoglobin Levels in Diabetes Type 2 Patients - A Single Blind, Randomized Control Trial.

BAKSON HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITA0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年5月2日

试验速览

暂无简介。

•PATIENTS WITH GLYCATED HAEMOGLOBIN LEVEL MORE THAN 6.5 AS PER ADA criteria 2021
•PATIENTS IN THE AGE GROUP 18 TO 59 YEARS

•Secondary causes of hyperglycemia such as pregnancy, pharmacotherapy such as corticosteroid therapies
•Patients who are critically ill and with severe complications like Neuropathy Retinopathy Foot ulcer and other complications of Diabetes and Bedridden patients
•Patients with Diabetes type 1
•Patients on Insulin Therapy
•Lactating females and those who are planning pregnancy
•Patient with any psychiatric disorder

发起方

BAKSON HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITA